| Dr Malcolm Gregory Floyd Jr, MD | |
|
122 Highway 280, Suite A, Americus, GA 31719-8645 | |
| (229) 931-7156 | |
| (229) 931-9472 |
| Full Name | Dr Malcolm Gregory Floyd Jr |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 17 Years |
| Location | 122 Highway 280, Americus, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023323516 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 064930 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Of Macon | Macon, GA | Home health agency |
| Phoebe Sumter Medical Center | Americus, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Phoebe Physician Group Inc | 8426112350 | 342 |
News Archive
Netakimab is a humanized anti-interleukin 17A antibody approved for the treatment of moderate-to-severe plaque psoriasis.
The night before Brian Gorzney planned to check into rehab for alcohol use, he began vomiting blood. First at 2 a.m. Then 5. And again at 11.
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced enrollment of the first patient in the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) trial which is designed to assess patient outcomes using a standardized, best practices approach in endoscopic vessel harvesting (EVH) for coronary artery bypass graft surgery (CABG) compared with open vein harvesting methods.
Factoring in the total number of days that extremely preterm infants require supplemental oxygen and tracking this metric for weeks longer than usual improves clinicians' ability to predict respiratory outcomes according to bronchopulmonary dysplasia severity, a research team led by Children's National Hospital writes in Scientific Reports.
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
› Verified 5 days ago
| Entity Name | Phoebe Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487899464 PECOS PAC ID: 8426112350 Enrollment ID: O20090121000583 |
News Archive
Netakimab is a humanized anti-interleukin 17A antibody approved for the treatment of moderate-to-severe plaque psoriasis.
The night before Brian Gorzney planned to check into rehab for alcohol use, he began vomiting blood. First at 2 a.m. Then 5. And again at 11.
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced enrollment of the first patient in the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) trial which is designed to assess patient outcomes using a standardized, best practices approach in endoscopic vessel harvesting (EVH) for coronary artery bypass graft surgery (CABG) compared with open vein harvesting methods.
Factoring in the total number of days that extremely preterm infants require supplemental oxygen and tracking this metric for weeks longer than usual improves clinicians' ability to predict respiratory outcomes according to bronchopulmonary dysplasia severity, a research team led by Children's National Hospital writes in Scientific Reports.
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Malcolm Gregory Floyd Jr, MD Po Box 827, Americus, GA 31709-0827 Ph: (229) 931-7156 | Dr Malcolm Gregory Floyd Jr, MD 122 Highway 280, Suite A, Americus, GA 31719-8645 Ph: (229) 931-7156 |
News Archive
Netakimab is a humanized anti-interleukin 17A antibody approved for the treatment of moderate-to-severe plaque psoriasis.
The night before Brian Gorzney planned to check into rehab for alcohol use, he began vomiting blood. First at 2 a.m. Then 5. And again at 11.
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced enrollment of the first patient in the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) trial which is designed to assess patient outcomes using a standardized, best practices approach in endoscopic vessel harvesting (EVH) for coronary artery bypass graft surgery (CABG) compared with open vein harvesting methods.
Factoring in the total number of days that extremely preterm infants require supplemental oxygen and tracking this metric for weeks longer than usual improves clinicians' ability to predict respiratory outcomes according to bronchopulmonary dysplasia severity, a research team led by Children's National Hospital writes in Scientific Reports.
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
› Verified 5 days ago
Dr. Michael Shane Busman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 922 E Jefferson St, Suite B, Americus, GA 31709 Phone: 229-924-2383 Fax: 229-924-0684 | |
Michael P Raines, M.D Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 122 Highway 280, Suite A, Americus, GA 31719 Phone: 229-931-7156 Fax: 229-931-9472 | |
Jill Suzanne Olek, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 922 E Jefferson St Ste B, Americus, GA 31709 Phone: 229-924-2383 Fax: 229-924-0684 | |
Ms. Bernadette D. Blount, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 126 Hwy 280, Americus, GA 31719 Phone: 229-931-1738 Fax: 229-931-7148 | |
Dr. Jeffrey Alan Nasworthy, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 126 Us Highway 280 W, Americus, GA 31719 Phone: 229-924-6011 | |
Mr. Randall Colby Nelson, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W College St, Americus, GA 31709 Phone: 229-591-3617 |